Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages

Ho, HaoHaoHoSUNG-LIANG YUChen, Hsuan-YuHsuan-YuChenYuan, Shin-ShengShin-ShengYuanKANG-YI SUHsu, Yi-ChiungYi-ChiungHsuHsu, Chung-PingChung-PingHsuChuang, Cheng-YenCheng-YenChuangChang, Ya-HsuanYa-HsuanChangLi, Yu-ChengYu-ChengLiCheng, Chiou-LingChiou-LingChengChang, Gee-ChenGee-ChenChangPAN-CHYR YANGLi, Ker-ChauKer-ChauLi2023-09-132023-09-132023-08-2001695002https://scholars.lib.ntu.edu.tw/handle/123456789/635365About 20% of stage I lung adenocarcinoma (LUAD) patients suffer a relapse after surgical resection. While finer substages have been defined and refined in the AJCC staging system, clinical investigations on the tumor molecular landscape are lacking.enMicroRNA expression; Relapse risk prediction; Somatic mutation; Stage I lung adenocarcinomas[SDGs]SDG3Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substagesjournal article10.1016/j.lungcan.2023.107352376572382-s2.0-85169808409https://api.elsevier.com/content/abstract/scopus_id/85169808409